This year the sessions are grouped in 3 different themes:
1. Chemical Biology
2. Technologies 
3. Therapeutic Areas

In addition, the programme contains three open sessions : First Time Disclosures, Emerging Topics and Late Breaking News. For these sessions, the talks will be selected from the submitted abstracts.

For most of the below topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts.

Chemical Biology

• Chemical Biology Approaches to Target Identification
  Session Chair: Prof. Herbert Waldmann, Max Planck Institute of Molecular Physiology, Germany
  
  
• Enzyme Activators and Positive Allosteric Modulators
  Session Chair: Prof. Joachim Mittendorf, Bayer, Germany
  
  
• Glycans in Medicinal Chemistry: Carbohydrate-Based Vaccines (EuChemS Session)
  Session Chair: Dr Sonsoles Martín-Santamaría, Biological Research Center, Spain
  
  
• Recent Advances in Targeted Protein Degradation
  Session Chair: Dr Gregory Hollingworth, Novartis, Switzerland
   
• Recent Developments in Kinase Inhibitors
  Session Chair: Prof. Stefan Laufer, University Tübingen, Germany
  
  
• Targeting the STING Pathway (Stimulator of Interferon Genes)
  Session Chair: Dr Thorsten Oost, Boehringer-Ingelheim, Germany
  
  
• The Spingosine-1-Phosphate Axis: Therapeutic Potential in Inflammation, Cancer, and More (ACSMEDI Session)
  Session Chair: Dr Tony Lee, Gilead Sciences, United States
  

Technologies

• Artificial Intelligence Applications in Medicinal Chemistry
  Session Chair: Dr Jonas Boström, AstraZeneca, Sweden
  
  
• Development of New Synthetic Methodologies for Drug Discovery (CPA Session)
  Session Chair: Dr Mingqiang Zhang, Amgen, China
  
  
• Expanding Medicinal Chemists’ Synthetic Toolbox
  Session Chair: Prof. György Miklós Keseru, Research Centre for Natural Sciences, Hungary
  
  
• New Chemical Modalities in Medicinal Chemistry
  Session Chair: Dr Eric Valeur, AstraZeneca, Sweden
  
  
• PET Imaging as a Tool in for in Vivo Drug Evaluation and Development (EANM Session)
  Session Chair: Dr Antony Gee, King's College London, United Kingdom
  
  
• Recent Developments in Nucleoside Medicinal Chemistry
  Session Chair: Dr Jared Cumming, Merck, Sharp & Dohme, United States
  
  
• Timing is Everything: Target Binding Kinetics and Pharmacokinetics
  Session Chair: Prof. Ad Ijzerman, University of Leiden, The Netherlands
  
  

Therapeutic Areas

• Addressing Infectious Diseases in the Developing Countries (AFMC Session)
  Session Chair: Dr Renate Griffith, UNSW Australia, Australia
  
  
• Breakthroughs in Polypharmacology Towards Neurological Disorders (ACSMEDI Session)
  Session Chair: Prof. Maria Laura Bolognesi, University of Bologna, Italy
  
  
• Cardiometabolic Diseases
  Session Chair: Dr Søren Tullin, Novo Nordisk, Denmark
  
  
• Immuno-Oncology: Novel Therapeutic Opportunities
  Session Chair: Dr Luc Van Hijfte, SCT & Mercachem-Syncom Group, The Netherlands
  
  
• Inflammatory and Autoimmune Diseases
  Session Chair: Prof. Stanislav Gobec, University of Ljubljana, Slovenia
  
  
• Life Science at the Interface of Agro and Pharma
  Session Chair: Dr Franz von Nussbaum, Bayer SAS, France
  
  
• Targeting Aggregated Proteins in Neurodegenerative Diseases with Small Molecules
  Session Chair: Dr Laurent Provins, UCB, Belgium
  
  
• Upcoming Treatment for NASH and Other Fibrotic Diseases
  Session Chair: Prof. Roberto Pellicciari, TES Pharma, Italy

Open Sessions (selected from submitted abstracts)

• First Time Disclosures
  Session Chair to be announced
  
  
• Emerging Topics
  Session Chair to be announced
  
  
• Late Breaking News
  Session Chair to be announced